Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
about
Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
description
clinical trial
@en
klinisch onderzoek
@nl
name
Open-label Phase 3 BTK Inhibit ...... ith Treatment-naive CLL or SLL
@en
type
label
Open-label Phase 3 BTK Inhibit ...... ith Treatment-naive CLL or SLL
@en
prefLabel
Open-label Phase 3 BTK Inhibit ...... ith Treatment-naive CLL or SLL
@en
P17
P1476
Randomized, Multicenter, Open- ...... or Small Lymphocytic Lymphoma
@en
P17
P3098
NCT01722487
P4844
P580
2013-03-01T00:00:00Z
P582
2015-05-01T00:00:00Z